Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy

Bernard F Hearon1, Kyle N Redelman2, Georges C Elhomsy3

  • 1Department of Orthopaedics, University of Kansas School of Medicine, Wichita, Kansas, USA.

Case Reports in Oncology
|January 14, 2021
PubMed